Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS)
CNY 19.91
(1.01%)
CNY 19.91
(1.01%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 621.05 Million CNY | 28.63% |
| 2022 | 482.83 Million CNY | 15.15% |
| 2021 | 419.32 Million CNY | 56.73% |
| 2020 | 267.54 Million CNY | -7.69% |
| 2019 | 289.82 Million CNY | -5.37% |
| 2018 | 306.25 Million CNY | 28.7% |
| 2017 | 237.96 Million CNY | -1.92% |
| 2016 | 242.62 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 595.13 Million CNY | -4.17% |
| 2024 Q3 | 736.35 Million CNY | 6.54% |
| 2024 Q2 | 691.17 Million CNY | 16.14% |
| 2023 Q3 | 592.37 Million CNY | 9.09% |
| 2023 Q2 | 543.01 Million CNY | 18.55% |
| 2023 Q1 | 458.03 Million CNY | -5.14% |
| 2023 FY | 621.05 Million CNY | 28.63% |
| 2023 Q4 | 621.05 Million CNY | 4.84% |
| 2022 Q4 | 482.83 Million CNY | 15.89% |
| 2022 Q3 | 416.63 Million CNY | -8.57% |
| 2022 Q2 | 455.67 Million CNY | 1.63% |
| 2022 FY | 482.83 Million CNY | 15.15% |
| 2022 Q1 | 448.38 Million CNY | 6.93% |
| 2021 Q4 | 419.32 Million CNY | -4.25% |
| 2021 Q3 | 437.91 Million CNY | 16.54% |
| 2021 Q2 | 375.76 Million CNY | 26.0% |
| 2021 FY | 419.32 Million CNY | 56.73% |
| 2021 Q1 | 298.22 Million CNY | 11.47% |
| 2020 FY | 267.54 Million CNY | -7.69% |
| 2020 Q4 | 267.54 Million CNY | 5.31% |
| 2020 Q3 | 254.05 Million CNY | 4.13% |
| 2020 Q2 | 243.98 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q2 | 293.99 Million CNY | 0.0% |
| 2019 FY | 289.82 Million CNY | -5.37% |
| 2019 Q4 | 289.82 Million CNY | 0.0% |
| 2018 FY | 306.25 Million CNY | 28.7% |
| 2017 FY | 237.96 Million CNY | -1.92% |
| 2016 FY | 242.62 Million CNY | 0.0% |